Isodiol International Inc. (CSE:ISOL) (OTC:ISOLF) (FSE:LB6A.F) (the "Company" or "Isodiol"), a global bioactive phytoceutical innovator specializing in the development of pharmaceutical and wellness products, is pleased to announce that it has finalized the definitive agreement to acquire 100% of Be Tr« Organics(TM), a cause driven organization specializing in holistic products for everyday health and balance in the human body with the goal to promote well-being within the mind, body, & soul.
This news is in connection with Isodiol's previous announcement confirming the Company had entered into a binding agreement with Be Tr« Organics. The press release can be viewed here.
"The acquisition with Be Tr« Organics is yet another major milestone for Isodiol and we are very pleased to have been able to finalize this partnership so quickly," said Marcos Agramont, CEO of Isodiol. "Not only does this partnership add diversity to the Isodiol's already strong portfolio of products, but gives the Company access to the mainstream distribution channels that Be Tr« Organics has been able to penetrate."
There have been no changes to the terms of this agreement. Isodiol will issue Be Tr« Organics $2,000,000 USD in stock, subject to a 36-month escrow.